Farmaseuttisen kemian laitos
Department of Pharmaceutical Chemistry

Julkaisut 1996
Publications 1996

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Auriola S et al. Analysis of oligonucleotides by on-column transient capillary isotachophoresis and capillary electrophoresis in poly(ethylene glycol)-filled columns.
2 Callaway JC. Farmacología de la ayahuasca.
3 Callaway JC. A report from the international conference of hoasca studies, november 2-4, 1995.
4 Callaway JC. PCP, STP, etc.
5 Callaway JC et al. Formation of tetrahydroharman (1-methyl-1,2,3,4-tetrahydro- beta-carboline) by helicobacter pylori in the presence of ethanol and tryptamine.
6 Callaway JC, Hemmilä AM. Cultivation of cannabis fiber varieties in central Finland.
7 Callaway JC, Laakkonen TT. Cultivation of cannabis oil seed varieties in Finland.
8 Callaway JC et al. Quantitation of n,n-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca.
9 Grob CS et al. Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil.
10 Gynther J, Järvinen T. Lääkeainekemian perusteet.
11 Holmalahti J. Morfiini.
12 Holmalahti J. Nitroyhdisteet.
13 Holmalahti J. Kiniini ja muut Cinchona-alkaloidit.
14 Holmalahti J. Kokaiini.
15 Holmalahti J. Digitalisglykosidit.
16 Holmalahti J. Strykniini.
17 Holmalahti J. Efedriini.
18 Holmalahti J. Peyote-kaktus ja meskaliini.
19 Holmalahti J. Khat.
20 Holmalahti J. Hirudiini.
21 Holmalahti J. Iho ja ikääntyminen. Kosmeettisten aineiden vaikutus.
22 Holmalahti J. Biotekniikka: 2000-luvun haaste farmasialle.
23 Holmalahti J et al. Rapid detection and isolation of DNA-binding compounds from Streptomyces xanthochromogenes.
24 Holmalahti J et al. Genotoxicity of dihydroabikoviromycin, a secondary metabolite of Streptomyces anulatus.
25 Holmalahti J, von Wright A. Antibiootteja tuottavien Streptomyces -kantojen geneettinen muokkaus.
26 Honkakoski P et al. Characterization of phenobarbital-inducible mouse Cyp2b10 gene transcription in primary hepatocytes.
27 Jarho P et al. Modified ß-cyclodextrin (SBE7-ß-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits.
28 Jarho P et al. The effect of SBE7-ß-CD with viscous vehicle on ocular delivery of pilocarpine prodrug in rabbits.
29 Jarho P et al. Hydroxypropyl-ß-cyclodextrin increases aqueous solubility and stability of anandamide.
30 Jarho P et al. Increase in aqueous solubility, stability and in vitro corneal permeability of anandamide by hydroxypropyl-ß-cyclodextrin.
31 Jarho P et al. The effects of HP-ß-CD on aqueous solubility, stability and in vitro corneal penetration of anandamide.
32 Jarvinen T et al., inventor. Novel pilocarpine derivatives and process for their preparation.
33 Järvinen T. Syklodekstriinit lääkevalmisteiden kehittämisessä.
34 Järvinen T, Järvinen K. Prodrugs for improved ocular drug delivery.
35 Koistinen J et al. Ethoxyresorufin-O-deethylase induction potency of polychlorinated diphenyl ethers in H411E rat hepatoma cells.
36 Lapinjoki S. Yleisimmunologia.
37 Lapinjoki S. Geenien biokemiallinen perusrakenne.
38 Lapinjoki S. Geenien käsittely- ja etsintämenetelmät.
39 Lapinjoki S. Yhdistelmä-DNA-teknologia lääketuotannossa ja -tutkimuksessa.
40 Manninen A et al. Determination of urinary 2-mercaptobenzothiazole (2-MBT), the main metabolite of 2-(thiocyanomethylthio)benzothiazole (TCMTB) in humans and rats.
41 Martinsen A, Gynther J. Liquid chromatography-thermospray mass spectrometry of toremifene and its derivatives.
42 Martinsen A, Gynther J. Retention behaviour of triphenylethylene derivatives in reverse phase liquid chromatography.
43 Martinsen A et al. Evaluation of reversed phase columns for the analysis of diphenylmethane derivatives.
44 Navajas C et al. Theoretical study of possible cholinergic substances by means of quantum and molecular mechanics calculations.
45 Navajas C et al. A rhodopsin-based model for melatonin recognition at its G protein-coupled receptor.
46 Navajas C et al. CoMFA of flavonoids with antimutagenic activity against 2-amino-3-methylimidazo[4,5-f]quinoline (IQ). [Online].
47 Navajas C et al. Comparative molecular field analysis (CoMFA) of MX compounds using different semi-empirical methods: LUMO field and its correlation with mutagenic activity.
48 Navajas Polo C. Computer-Aided Molecular Design Applied to Different Biologically Active Compounds.
49 Nevalainen T, Kolehmainen E. NMR spectra of some chlorinated diphenyliodonium salts and iodobenzenes.
50 Pate DW et al. Effects of topical anandamides on intraocular pressure in normotensive rabbits.
51 Poso A. Comparative molecular field analysis (CoMFA) ja sen soveltaminen eräiden biologisesti aktiivisten yhdisteiden tutkimiseen.
52 Saarinen-Savolainen P et al. Amphiphilic properties of pilocarpine prodrugs.
53 Suhonen P et al. Rate control of ocular pilocarpine delivery with bispilocarpic acid diesters.
54 Suihko E et al. Partial least squares (pls) analysis in prediction of contact angles for pharmaceutical materials.
55 Åkerman S et al. Segregation of aflp markers in betula pendula (roth).

Farmaseuttisen kemian laitos Department of Pharmaceutical Chemistry
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008